Pulmonary neuroendocrine carcinoid tumors
Annals of Thoracic Medicine · 2021-07 · 16 (3) · 274-279
DOI: 10.4103/atm.atm_599_20 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Thoracic Medicine, 2021-07. Verfasst von Ana Karina Patané und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic, Hospital De Rehabilitación Respiratoria María Ferrer, Alexander Fleming, Buenos Aires, Argentina. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
INTRODUCTION: There are several factors predicting evolution in carcinoid tumors (CT) to date including the Ki67 role. AIMS: The aim of this study is to identify a KI67 cut-off point for a population of CT and determine its prognostic implication in global and disease-free survival. METHODS: Hematoxylin-eosin slides of 102 CT were revised. The percentage of cells expressing Ki 67 was determined manually. STATISTICAL ANALYSIS: The variables were compared with the t-test or the Wilcoxon test according to their distribution, the categorical ones with Chi-square or Fisher's test. The best cut-off point was established by constructing receiver operating characteristic curves, then using that value as a dichotomous variable. RESULTS: 72 typical carcinoids (TC) and 30 atypical carcinoids (AC) were analyzed; 66% were female. Median age (TC 38 vs. AC 51, P = 0.001), Ki67 expression (TC 0.63 vs. AC 2, P = 0.003), tumor size (TC 2.5 vs. AC 2.6, P = 0.001), the percentage relapse (TC 3.4% vs. AC 23%, P = 0.006), and the number of deaths (TC 1 vs. AC 4, P = 0.042) were significantly higher in the AC subgroup. The best cut-off point for Ki 67 was 0.755 (area under the curve AUC 0.564, 95% confidence interval 0.270–0.857), with no significant differences found in the disease-free and overall survival curves when considering values < or ≥ at the established cut-off point. The best cut-off point of the Ki-67 when exclusively analyzing AC was 1.18. When using this value as a predictive variable, a marginal statistical association was observed between Ki-67 expression, mortality ( P = 0.077), and the frequency of relapses ( P = 0.054). CONCLUSIONS: Histological type is the best predictor of prognosis in the carcinoid tumor group. In the AC subgroup, the marginal association between mortality, frequency of relapses and Ki values 67 ≥ 1.18 has clinical relevance future analyses are required to determine the real predictive value of this variable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic, Hospital De Rehabilitación Respiratoria María Ferrer, Alexander Fleming, Buenos Aires, Argentina.
- Department of Pathology, Hospital De Rehabilitación Respiratoria María Ferrer, Alexander Fleming, Buenos Aires, Argentina.
- Department of Thoracic Surgery and Pathology, Instituto Médico Especializado, Alexander Fleming, Buenos Aires, Argentina.
Zitieren
APA
Patané, A. K., Guma, G., Rayá, M., Rosales, A., Astorino, W., & Rosenberg, M. (2021). Pulmonary neuroendocrine carcinoid tumors. Annals of Thoracic Medicine, 16(3), 274-279. https://doi.org/10.4103/atm.atm_599_20
Vancouver
Patané AK, Guma G, Rayá M, Rosales A, Astorino W, Rosenberg M. Pulmonary neuroendocrine carcinoid tumors. Annals of Thoracic Medicine. 2021;16(3):274-279. doi:10.4103/atm.atm_599_20
BibTeX
@article{Patan2021,
author = {Patané, Ana Karina and Guma, Gabriela and Rayá, Mercedes and Rosales, Adolfo and Astorino, Walter and Rosenberg, Moisés},
title = {Pulmonary neuroendocrine carcinoid tumors},
journal = {Annals of Thoracic Medicine},
year = {2021},
volume = {16},
number = {3},
pages = {274--279},
doi = {10.4103/atm.atm_599_20}
}
EUVIMED